🇺🇸 FDA
Patent

US 6482411

Methods of reducing bone loss with CD40 ligand

expired A61KA61K2039/505A61K38/00

Quick answer

US patent 6482411 (Methods of reducing bone loss with CD40 ligand) held by The Board of Regents of the University of Texas System expires Mon Nov 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Nov 19 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
34
CPC classes
A61K, A61K2039/505, A61K38/00, A61P, A61P19/10